- Coordinator
- International Iberian Nanotechnology Laboratory, Portugal
- Runs
- 1 January 2023 to 31 December 2026
- Status
- Running
- EU funding
- €2.7m
- Total cost
- €2.7m
- Partners
- 12 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101092971
What the project is doing
In the project's own words, from its summary on CORDIS.
The incidental, accidental, or intentional release of manufactured nanomaterials into the environment and its exposure to humans is inevitable due to the exponential growth in invention, production, and use of them. It can have a huge impact in our health specially in the most sensible and exposed human body organs such us lungs, stomach, and brain. iCare aim to to develop a resilient and adaptive set of advanced imaging technologies to quantify physical-chemistry properties for ANMC in complex matrices.
The main objective will focus on a integrated model system to characterize and predict the impact of nanomaterials on brain health to prevent the toxicity nanomaterials. The project makes accessible for industry a set of techniques and methodologies to evaluate changes in morphology, chemical composition and reactivity of nanomaterials when exposed to complex homogenous matrices mimicking environmental and biological exposure, with a particular emphasis on high-resolution imaging methodologies.
To achieve this goal the project the project brings together in the consortium 11 partners from different backgrounds such as RTOs, SMEs, industries and universities from different EU and non-eu countries and coming from different fields like nanotech, toxicology, advanced materials, advanced imaging, …During the 48 months long of the project, the consortium will work on the development of different activities to achieve the following results: 1)new imaging methods achieving new high resolution methodologies and new super resolution imaging techniques 2)development of toxicology testing protocols and addressing current gaps in nanotoxicology, 3)development of tools and methods bringing the gap in vitro and in vivo testing, 4)efficiency of materials and product development 5)Delivery of reliable data and improved data reporting and finally development of harmonised standardised test methods that can be used in regulatory frameworks.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| International Iberian Nanotechnology Laboratory | Braga | Portugal | Coordinator |
| The University of Sydney | Sydney | Australia | Associatedpartner |
| Nanotechnology Industries Association | Bruxelles / Brussel | Belgium | Participant |
| Temas Solutions GmbH | Hausen | Switzerland | Associatedpartner |
| Avanzare Innovacion Tecnologica SL | Navarrete | Spain | Participant |
| Fundacion Gaiker | Zamudio | Spain | Participant |
| Fondazione Istituto Italiano Di Tecnologia | Genova | Italy | Participant |
| Optics11 B.v. | Amsterdam | Netherlands | Participant |
| Optics11 Life B.V. | Amsterdam | Netherlands | Participant |
| Instytut Chemii Bioorganicznej Polskiej Akademii Nauk | Poznan | Poland | Participant |
| Advanced Material Development Ltd | Farnborough | United Kingdom | Associatedpartner |
| Versarien plc | Longhope Gloucestershire | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI